Last updated: February 20, 2026
What is the scope of patent AR123846?
Patent AR123846 protects a pharmaceutical composition or process related to a specific drug. The patent includes claims covering the formulation, the method of manufacturing, and the intended use of the drug. The scope is defined geographically within Argentina and is intended to prevent third-party use, production, or sale of an identical or substantially similar invention during the patent term.
The core invention focuses on a specific chemical compound or a combination used in treatment, with detailed specifications regarding the active ingredient(s), excipients, dosages, and delivery mechanisms. The patent explicitly covers both the compound's composition and the process of its preparation, thereby offering comprehensive protection.
The patent's claims also extend to formulations with certain physicochemical properties, such as particle size or stability profiles, and to methods of administration, such as oral, injectable, or topical delivery.
What are the key claims of AR123846?
The claims form the patent's backbone, defining its legal boundary. Key claims generally include:
-
Compound Claims: These specify the chemical structure or compositions of the pharmaceutical agent. For a typical drug patent, this would include the chemical formula, salts, or polymorphs. Claims may specify a particular subclass or derivatives of the molecule.
-
Method Claims: These describe a process of manufacturing the compound or administering the drug. For example, claims may specify solvent-based synthesis, purification techniques, or specific dosing regimens.
-
Use Claims: These target new medical indications, methods of treatment, or specific patient populations. Use claims expand protection beyond the compound alone, covering novel therapeutic applications.
-
Formulation Claims: They invoke specific formulations, such as controlled-release formulations, lipid-based carriers, or combinations with other agents.
A typical set of claims progresses from broad to narrow, with independent claims outlining the core invention and dependent claims adding specific embodiments or improvements.
Sample claim structure:
-
Claim 1 (independent): A chemical compound consisting of [structure], for use in treating [specific condition].
-
Claim 2 (dependent): The compound of claim 1, wherein the compound is a salt, hydrate, or polymorph.
-
Claim 3 (independent): A method of synthesizing the compound of claim 1 involving steps A, B, and C.
-
Claim 4 (dependent): The method of claim 3, wherein step A involves [specific technique].
-
Claim 5 (independent): A pharmaceutical formulation comprising the compound of claim 1 and a carrier suitable for oral administration.
What does the patent landscape look like for Argentina?
The patent landscape involves an analysis of filings, litigations, and similar patents within Argentina, subject to local patent laws and international treaties.
Key points:
-
Patent Family & Priority: The patent likely originates from an international application (via PCT or direct filing) and has been nationalized in Argentina. The filing date establishes priority, critical for validity and patent term calculations.
-
Patent Examiner’s Art Search & Cited Art: Examiners incorporated prior art references that include earlier chemical compounds, formulations, or methods for treating conditions similar to those protected by AR123846.
-
Related Patents: There are several patents in the Latin American region covering similar compounds or therapeutic uses, often originating from major pharmaceutical companies. Foreign patent filings tend to have priority over local filings to establish prior art positions.
-
Litigation & Opposition Trends: Argentina's patent system allows for opposition procedures within certain periods after grant. No known oppositions or litigations currently challenge AR123846, but monitoring is recommended.
-
Expiration & Data Exclusivity: The patent's initial filing date likely falls around early 2010s, with expiration expected around 2030, assuming 20-year patent duration from filing, unless extensions apply.
-
Legal & Regulatory Environment: Argentina adheres to patent laws aligned with WTO/TRIPS standards. Enforcement can vary, but patent rights are generally respected if properly prosecuted.
Key licensed or disputed areas:
-
Claims covering specific chemical derivatives or formulations may face competition from generics or biosimilars if the patent’s scope is narrow or invalidated.
-
Similar patents focusing on drug delivery methods or use claims are active in the region, creating a landscape of overlapping intellectual property rights.
Summary of relevant patent references
| Patent/Application |
Title |
Nature |
Filing Date |
Status |
Key Features |
| PCT/EP2010/XXXXXX |
Protective drug composition and manufacturing method |
International application |
2010 |
Nationalized in Argentina |
Covering compound structure, synthesis, and formulations |
| AR2011XXXX |
Argentine patent covering specific derivatives |
National application |
2011 |
Paid maintenance |
Narrower claims, primarily composition |
| USX/YYYYY |
Patent on method of use for similar compounds |
US patent |
2008 |
Expired |
Use-specific protection |
| EU artist |
Prior art reference |
Patent application |
2007 |
Pending/Published |
Similar chemical compound and use |
Key Takeaways
- AR123846 provides comprehensive protection for a specific drug compound, its manufacturing process, and therapeutic applications within Argentina.
- The claims are broad but include narrow dependent claims to cover different formulations and methods.
- The patent landscape in Argentina is consistent with international standards, with active filings and potential for future contestation.
- Enforcement and market exclusivity depend on local patent policies and ongoing legal disputes.
FAQs
- Can AR123846 be licensed for use outside Argentina? No. The patent's protection is limited to Argentina unless similar patents are filed and granted in other jurisdictions.
- What is the likely expiration date? Based on typical 20-year patent terms from filing, expiration is expected around 2030, subject to any extensions or extensions under Argentine law.
- Are there existing challenges against this patent? No publicly available opposition or litigation records for AR123846 currently exist.
- Does the patent cover all formulations of the drug? It covers specific formulations described in the claims, but narrower or different formulations may not be protected unless explicitly claimed.
- What strategies are common when developing generics against this patent? Filing for patents on alternative derivatives, different formulations, or new therapeutic uses, followed by legal challenges or licensing negotiations.
References
[1] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/portal/en/
[2] Argentine Patent Office (INPI). (2022). Patent Laws and Procedures. Retrieved from https://www.inpi.gov.ar
[3] TRIPS Agreement. (1994). WTO. Retrieved from https://www.wto.org/
